Results 221 to 230 of about 542,367 (279)

Comparison of intestinal histopathological changes following teclistamab, BCMA‐directed CAR T, CD19‐directed CAR T and rituximab therapies

Histopathology, EarlyView.
This is a retrospective review of intestinal tract biopsies from patients treated with various cellular immunotherapies (BCMA and CD19‐directed CAR T, teclistamab and rituximab therapies). We found distinct but overlapping histologic patterns across treatment groups, with lamina propria plasma cell depletion, crypt apoptotic bodies and active ...
Olivia J Leung, Esther Baranov, Isairis Peralta Valerio, Robin Collingwood, Natalie Respond, Don Siegel, Pooja Devi, Kristen M. Stashek   +7 more
wiley   +1 more source

Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis

International Journal of Dermatology, EarlyView.
Chronic prurigo, including prurigo nodularis, is a chronic, often treatment‐refractory condition characterized by persistent pruritus and chronic scratch lesions. Advances in the understanding of its underlying pathophysiology have enabled the development of novel targeted therapies; however, management remains challenging due to the expanding range of
Simon M. Mueller, Helmut Beltraminelli, Wolf‐Henning Boehncke, Maximilian Böhm, Antonio Cozzio, Peter Häusermann, Ahmad Jalili, Antonios G. A. Kolios, Claudia Lang, Eva Loos, Christoph Schlapbach, Curdin Conrad   +11 more
wiley   +1 more source

Dilution‐Endpoint Comparison of a Flow Cytometric Platelet Activation Assay With PF4/Heparin ELISA and a Lateral Flow Immunoassay in Suspected HIT

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Heparin‐induced thrombocytopenia (HIT) is a rare but potentially life‐threatening, immune‐mediated adverse reaction to heparin. PF4‐dependent immunoassays are sensitive screening tests, but they detect both platelet‐activating and nonactivating antibodies; therefore, positive results require interpretation in clinical context and,
Elvira Maličev, Matjaž Urbajs, Katerina Jazbec Gradišar, Ana Kolenc, Primož Rožman   +4 more
wiley   +1 more source

Heterogeneity of IgA deficiency in childhood

Pediatric Allergy and Immunology, 1991
Fifty‐one children with total or partial IgA deficiency were compared for clinical and laboratory features. Serum IgG were higher in total IgA deficiency. Moreover, while no subject with partial IgA deficiency showed autoantibodies, 48% of the group with total IgA deficiency showed one or more autoantibodies.
Claudio Pignata, F Ciccimarra
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

IgA deficiency and autoimmunity

Autoimmunity Reviews, 2014
IgA is the most abundant immunoglobulin in the human body, and performs a very specialized role which involves mucosal immunity, development of tolerance and protection against infection. IgA is the key immunoglobulin in the respiratory and gastrointestinal tracts, which provide the most intimate interface between the environment and self.
M Eric Gershwin
exaly   +3 more sources

IgA deficiency in wolves

Developmental & Comparative Immunology, 2013
Low mean concentrations of serum immunoglobulin A (IgA) and an increased frequency of overt IgA deficiency (IgAD) in certain dog breeds raises the question whether it is a breeding-enriched phenomenon or a legacy from the dog's ancestor, the gray wolf (Canis lupus).
Marcel, Frankowiack, Lars, Hellman, Yaofeng, Zhao, Jon M, Arnemo, Miaoli, Lin, Katarina, Tengvall, Torsten, Møller, Kerstin, Lindblad-Toh, Lennart, Hammarström   +8 more
openaire   +3 more sources

Selective IgA deficiency.

Annals of allergy, 1986
Selective IgA deficiency is the most common form of immunodeficiency. Certain select populations, including allergic individuals, patients with autoimmune and gastrointestinal tract disease and patients with recurrent upper respiratory tract illnesses, have an increased incidence of this disorder.
Burks Jr., A. W., Steele, R. W.
openaire   +4 more sources

Iga deficiency

, 2020
IgA deficiency (D-IgA) in the paediatric population is often an occasional finding during tests performed for other reasons in children in whom an immunodeficiency disorder is not suspected. D-IgA is the most common primary immunodeficiency with a variable prevalence according to ethnicity, estimated on 1 case/600 in the Caucasian population.
Guiducci C., Marchetti F.
core   +3 more sources